New combo therapy shows promise for deadly IPF Flare-Ups
NCT ID NCT03286556
First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study tested a combination of plasma exchange, rituximab, and intravenous immunoglobulin in 82 people with a sudden, severe worsening of idiopathic pulmonary fibrosis (IPF). The goal was to see if this treatment could improve survival compared to usual care with antibiotics and steroids. The approach targets abnormal immune activity thought to cause lung damage during these acute episodes.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- a combination of plasma exchange, rituximab, and intravenous immunoglobulin (IVIG)
- What this could lead to
- If it works, this could offer a new treatment option for sudden, life-threatening worsening of IPF, a condition with no current effective therapy.
- What could go wrong
- This is a Phase 2 trial with only 82 participants, so results may not apply to all patients. The treatment is intensive and carries risks like infection from immune suppression.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for IDIOPATHIC PULMONARY FIBROSIS, ACUTE FATAL FORM are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Baylor University Medical Center
Houston, Texas, 77030, United States
-
Dan Dilling
Chicago, Illinois, 60611, United States
-
Temple University Hospital
Philadelphia, Pennsylvania, 19140, United States
-
Thomas Jefferson University Medical Center
Philadelphia, Pennsylvania, 19107, United States
-
University of Alabama at Birmingham
Birmingham, Alabama, 35233, United States
-
University of Pittsburgh Medical Center
Pittsburgh, Pennsylvania, 15213, United States
-
University of Utah Medical Center
Salt Lake City, Utah, 84112, United States